Editorial: Autoimmune and inflammatory rheumatic diseases: Identifying biomarkers of response to therapy with biologics: Volume II-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Editorial: Autoimmune and inflammatory rheumatic diseases: Identifying biomarkers of response to therapy with biologics: Volume II

Published:2023-02-28 Issue: Volume:14 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Giuliani Anna Lisa,Bortoluzzi Alessandra,Oliviero Francesca

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference13 articles.

1. Osteoarthritis: Pathology, diagnosis, and treatment options;Abramoff;Med. Clin. North Am.,2020

2. P2X7 receptor expression in patients with serositis related to systemic lupus erythematosus;Furini;Front. Pharmacol.,2019

3. Promising therapeutic targets for treatment of rheumatoid arthritis;Huang;Front. Immunol.,2021

4. Biologic therapy in the idiopathic inflammatory myopathies;Khoo;Rheumatol. Int.,2020

5. Osteoimmunological insights into the pathogenesis of ankylosing spondylitis;Liu;J. Cell Physiol.,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP